Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Cash from Operations (2020 - 2025)

Historic Cash from Operations for Beauty Health (SKIN) over the last 6 years, with Q3 2025 value amounting to $9.6 million.

  • Beauty Health's Cash from Operations fell 647.6% to $9.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.8 million, marking a year-over-year increase of 80372.19%. This contributed to the annual value of $16.1 million for FY2024, which is 2582.07% down from last year.
  • Per Beauty Health's latest filing, its Cash from Operations stood at $9.6 million for Q3 2025, which was down 647.6% from $9.6 million recorded in Q2 2025.
  • Beauty Health's 5-year Cash from Operations high stood at $22.0 million for Q2 2023, and its period low was -$38.5 million during Q1 2022.
  • In the last 5 years, Beauty Health's Cash from Operations had a median value of $1.3 million in 2021 and averaged -$3.9 million.
  • In the last 5 years, Beauty Health's Cash from Operations skyrocketed by 5528518.52% in 2021 and then crashed by 1063724.83% in 2022.
  • Over the past 5 years, Beauty Health's Cash from Operations (Quarter) stood at $3.3 million in 2021, then plummeted by 264.47% to -$5.4 million in 2022, then rose by 4.13% to -$5.2 million in 2023, then skyrocketed by 418.61% to $16.5 million in 2024, then plummeted by 41.43% to $9.6 million in 2025.
  • Its last three reported values are $9.6 million in Q3 2025, $9.6 million for Q2 2025, and $3.0 million during Q1 2025.